Studies have examined the relationship between NNMT inhibition and cellular NAD+ levels, which are critical for numerous enzymatic reactions including those involving sirtuins and PARPs
Early research suggests 5-Amino-1MQ may influence NNMT-related metabolic pathways, but human weight-loss results are not established
Important safety questions include product purity, dose accuracy, drug interactions, liver and kidney considerations, blood sugar changes, cardiovascular risk, pregnancy or breastfeeding status, and long-term exposure
TABLE 2 Characteristics of the included studies
Memorial Sloan Kettering Cancer Center
If a scheduled amount is missed, there is no approved guidance and doubling is not supported by evidence